Reliability and validity of diabetes specific Health Beliefs Model scales in patients with diabetes and serious mental illness

Diabetes Research and Clinical Practice

Volumn 92, Issue 3, 2011, Pages 342-347

  Gutierrez, Jennifer ^a   Long, Judith A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes; Health Beliefs Model; Serious mental illness

Indexed keywords

ADULT; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEALTH BELIEF MODEL; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; RATING SCALE; RELIABILITY; VALIDITY;

DATA COLLECTION; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 79957997874     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.02.018     Document Type: Article

References (32)

1. Sokal J., Messias E., Dickerson F.B., Kreyenbuhl J., Brown C.H., Goldberg R.W., et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 2004, 192(6):421-427.
2. Cohen D., Stolk R.P., Grobbee D.E., Gispen-de Wied C.C. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. Diabetes Care 2006, 29(April (4)):786-791.
3. Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000, 26(January (4)):903-912.
4. Dixon L.B., Kreyenbuhl J.A., Dickerson F.B., Donner T.W., Brown C.H., Wolheiter K., et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatr Serv 2004, 55(August (8)):892-900.
5. Krein S.L., Bingham C.R., McCarthy J.F., Mitchinson A., Payes J., Valenstein M., et al. Patients with comorbid serious mental illness. Psychiatr Serv 2006, 57(July (7)):1016-1021.
6. Whyte S., Penny C., Phelan M., Hippisley-Cox J., Majeed A. Quality of diabetes care in patients with schizophrenia and bipolar disorder: cross-sectional study. Diabetic Med 2007, 24(12):1442-1448.
7. Kreyenbuhl J., Dixon L.B., McCarthy J.F., Soliman S., Ignacio R.V., Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?. Schizophr Bull 2010, 36(March (2)):428-435.
8. Krapek K., King K., Warren S.S., George K.G., Caputo D.A., Mihelich K., et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004, 38(September (9)):1357-1362.
9. Pladevall M., Williams L.K., Potts L.A., Divine G., Xi H., Lafata J.E. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004, 27(December (12)):2800-2805.
10. National Diabetes Fact Sheet National Diabetes Fact Sheet 2007 2007, http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf.
11. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A.W. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589.
12. Vijan S., Hofer T.P., Hayward R.A. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997, 127(9):788-795.
13. Manley S. Haemoglobin A1c-a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003, 41(September (9)):1182-1190.
14. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(August (7258)):405-412.
15. Stratton I.M., Kohner E.M., Aldington S.J., Turner R.C., Holman R.R., Manley S.E., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6years from diagnosis. Diabetologia 2001, 44(February (2)):156-163.
16. Molyneaux L.M., Constantino M.I., McGill M., Zilkens R., Yue D.K. Better glycaemic control and risk reduction of diabetic complications in type 2 diabetes: comparison with the DCCT. Diabetes Res Clin Pract 1998, 42(November (2)):77-83.
17. Rosenstock I. Historical origins of the health belief model. Health Educ Monogr 1974, 2(4).
18. Janz N.K., Becker M.H. The health belief model: a decade later. Health Educ Q 1984, 11(Spring (1)):1-47.
19. Aalto A.-M., Uutela A. Glycemic control, self-care behaviors, and psychosocial factors among insulin treated diabetics: a test of an extended health belief model. Int J Behav Med 1997, 4(3):191-214.
20. Dickinson D., Iannone V.N., Wilk C.M., Gold J.M. General and specific cognitive deficits in schizophrenia. Biol Psychiatry 2004, 55(8):826-833.
21. Dickinson D., Ragland J.D., Gold J.M., Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath Defeats David?. Biol Psychiatry 2008, 64(9):823-827.
22. Blow F.C., Zeber J.E., McCarthy J.F., Valenstein M., Gillon L., Bingham C.R. Ethnicity and diagnostic patterns in veterans with psychoses. Soc Psychiatry Psychiatr Epidemiol 2004, 39(10):841-851.
23. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
24. Shi L., Liu J., Koleva Y., Fonseca V., Kalsekar A., Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. PharmacoEconomics 2010, 28(12):1097-1107. doi:10.2165/11537400-000000000-00000.
25. Cohen H.W., Shmukler C., Ullman R., Rivera C.M., Walker E.A. Measurements of medication adherence in diabetic patients with poorly controlled HbA1c. Diabetic Med 2010, 27(2):210-216.
26. Chao J., Nau D.P., Aikens J.E., Taylor S.D. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Soc Adm Pharm 2005, 1(December (4)):508-525.
27. Heisler M., Vijan S., Anderson R.M., Ubel P.A., Bernstein S.J., Hofer T.P. When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make?. J Gen Intern Med 2003, 18(11):893-902.
28. Nelson K., McFarland L., Reiber G. Factors influencing disease self-management among veterans with diabetes and poor glycemic control. J Gen Intern Med 2007, 22(4):442-447.
29. Ferraro LA, Price J.H., Desmond S.M., Roberts S.M. Development of a diabetes locus of control scale. Psychol Rep 1987, 61(3):763-770.
30. Health measurement scales: a practical guide to their development and use 2008, Oxford Medical Publications, Oxford, England. Fourth ed. G.N. David Streiner (Ed.).
31. Tillotson L.M., Smith M.S. Locus of control, social support, and adherence to the diabetes regimen. Diabetes Educ 1996, 22(April (2)):133-139.
32. Nagasawa M., Smith M.C., Barnes J.H., Fincham J.E. Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. Diabetes Educ 1990, 16(June (3)):192-200.